You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023242013
Dec 20234706
Jan 20243800
Feb 20243004
Mar 20243006
Apr 20241605
May 20242201
Jun 20241203
Jul 2024803
Aug 20241802
Sep 20242003
Oct 20241001
Nov 20244409
Dec 20241405
Jan 20252202
Feb 2025405
Mar 2025004
Apr 2025102
May 2025005
Jun 2025105
Total579084